Publicaciones en las que colabora con Javier Sánchez-González (19)

2023

  1. Absence of Myocardial Involvement After SARS-CoV-2 Vaccination in Asymptomatic Adolescents

    Journal of Cardiovascular Translational Research

  2. Magnetic resonance imaging reference values for cardiac morphology, function and tissue composition in adolescents

    eClinicalMedicine, Vol. 57

2021

  1. Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences

    JACC: Cardiovascular Imaging, Vol. 14, Núm. 9, pp. 1742-1754

  2. Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study

    Basic Research in Cardiology, Vol. 116, Núm. 1

  3. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity

    Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143

  4. Time-efficient three-dimensional transmural scar assessment provides relevant substrate characterization for ventricular tachycardia features and long-term recurrences in ischemic cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 133, pp. 39-47

  2. Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy)

    Journal of Cardiovascular Magnetic Resonance, Vol. 22, Núm. 1

  3. Metoprolol blunts the time-dependent progression of infarct size

    Basic Research in Cardiology, Vol. 115, Núm. 5

2019

  1. Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial

    JACC: Cardiovascular Imaging, Vol. 12, Núm. 7, pp. 1188-1198

  2. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity

    Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791

2018

  1. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318

2017

  1. Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition after Myocardial Infarction

    Circulation Research, Vol. 121, Núm. 4, pp. 439-450

  2. El volumen extracelular no se asocia a arritmias malignas en miocardiopatía hipertrófica de alto riesgo

    Revista Espanola de Cardiologia, Vol. 70, Núm. 11, pp. 933-940

  3. Impacto del territorio miocárdico infartado en la cuantificación del área en riesgo mediante cardiorresonancia magnética

    Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 323-330

2016

  1. Impact of the Timing of Metoprolol Administration during STEMI on Infarct Size and Ventricular Function

    Journal of the American College of Cardiology, Vol. 67, Núm. 18, pp. 2093-2104

2015

  1. Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension

    JACC: Cardiovascular Imaging, Vol. 8, Núm. 1, pp. 76-82

  2. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: Imaging and histological tissue characterization

    Journal of the American College of Cardiology, Vol. 65, Núm. 4, pp. 315-323

2014

  1. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362